Article Details

FDA Approves Trastuzumab Biosimilar for the Treatment of HER2-Overexpressing Breast ...

Retrieved on: 2024-04-30 19:01:58

Tags for this article:

Click the tags to see associated articles and topics

FDA Approves Trastuzumab Biosimilar for the Treatment of HER2-Overexpressing Breast .... View article details on hiswai:

Excerpt

Shanghai Henlius Biotech (Henlius), a Shanghai-based biopharmaceutical company, announced the FDA approval of HERCESSI (HLX002; trastuzumab-strf), a ...

Article found on: www.biopharminternational.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up